An Overview of Premenstrual Voice Syndrome: Definition, Treatment, and Future Trajectories

Abstract

For classical singers, performing in peak condition is optimal at all times in an industry which demands excellence. The slightest variability in a singer’s physiology can influence sound quality and production; in severe instances, a singer’s career longevity may be compromised. Researchers have observed an effect of menstrual cycle hormone variability on the voice, compromising tone quality, agility, and stamina. For a subset of these singers, the effect of hormone variability on voice production is especially severe. This phenomenon has been termed premenstrual voice syndrome (PMVS) among singers, although there has been little empirical research on PMVS, which complicates matters related to defining, taxonomizing, and treating the condition. This article offers an overview of existing research related to PMVS, identifies gaps in definitional and categorical boundaries between PMVS and premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), and offers recommendations for symptom management as well as suggestions for pedagogues and teachers to better educate themselves and their students about PMVS.